Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis
- PMID: 237834
- PMCID: PMC415257
- DOI: 10.1128/iai.12.1.137-142.1975
Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis
Abstract
Ribonucleic acid (RNA)-rich extracts derived from the attenuated strain of Francisella tularensis (strain LVS) protected Swiss mice against lethal challenge with F. tularensis strain 425 but not against strain SCHU S4. No killed preparation, including an RNA-rich extract from SCHU S4 itself, offered protection against strain SCHU S4 in contrast to the high level of protection offered against this strain by vaccination with live strain LVS. The protective activity observed against strain 425 was sensitive to ribonuclease but not to Pronase. Protective activity is not a general property of bacterial RNA, since RNA-rich extracts from Staphylococcus aureus offered no protection against tularemia, although disc gel electrophoresis showed similar kinds and amounts of RNA in preparations form F. tularensis and S. aureus. Furthermore, inability to localize activity to a specific region in sucrose gradients suggests a structural rather than an informational role for the RNA in such extracts. RNA-rich extracts from F. tularensis but not from S. aureus were efficient inducers of F. tularensis opsonins in mouse serum, suggesting one mechanism by which such extracts confer protection.
Similar articles
-
Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.Clin Vaccine Immunol. 2014 Feb;21(2):212-26. doi: 10.1128/CVI.00738-13. Epub 2013 Dec 18. Clin Vaccine Immunol. 2014. PMID: 24351755 Free PMC article.
-
Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates.Virulence. 2020 Dec;11(1):283-294. doi: 10.1080/21505594.2020.1746557. Virulence. 2020. PMID: 32241221 Free PMC article.
-
Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.Mol Immunol. 2013 May;54(1):58-67. doi: 10.1016/j.molimm.2012.10.043. Epub 2012 Nov 28. Mol Immunol. 2013. PMID: 23201853
-
Nature of protective immunity to Francisella tularensis.Rev Infect Dis. 1989 May-Jun;11(3):440-51. Rev Infect Dis. 1989. PMID: 2665002 Review.
-
Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.Infect Drug Resist. 2014 Sep 18;7:239-51. doi: 10.2147/IDR.S53700. eCollection 2014. Infect Drug Resist. 2014. PMID: 25258544 Free PMC article. Review.
Cited by
-
Immunoprotective activity of ribosomes from Haemophilus influenzae.Infect Immun. 1977 Feb;15(2):453-60. doi: 10.1128/iai.15.2.453-460.1977. Infect Immun. 1977. PMID: 300360 Free PMC article.
-
Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.Infect Immun. 1978 Jan;19(1):58-65. doi: 10.1128/iai.19.1.58-65.1978. Infect Immun. 1978. PMID: 304844 Free PMC article.
-
Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.Infect Immun. 1981 Mar;31(3):896-905. doi: 10.1128/iai.31.3.896-905.1981. Infect Immun. 1981. PMID: 6785242 Free PMC article.
-
Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.Infect Immun. 1976 Aug;14(2):345-54. doi: 10.1128/iai.14.2.345-354.1976. Infect Immun. 1976. PMID: 9362 Free PMC article.
-
Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.Infect Immun. 1978 Jun;20(3):760-9. doi: 10.1128/iai.20.3.760-769.1978. Infect Immun. 1978. PMID: 27461 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources